Othman Al-Sawaf, Jakob Weiss, Marcin Skrzypski, Jie Min Lam, Takahiro Karasaki, Francisco Zambrana, Andrew C Kidd, Alexander M Frankell, Thomas B K Watkins, Carlos Martínez-Ruiz, Clare Puttick, James R M Black, Ariana Huebner, Maise Al Bakir, Mateo Sokač, Susie Collins, Selvaraju Veeriah, Neil Magno, Cristina Naceur-Lombardelli, Paulina Prymas, Antonia Toncheva, Sophia Ward, Nick Jayanth, Roberto Salgado, Christopher P Bridge, David C Christiani, Raymond H Mak, Camden Bay, Michael Rosenthal, Naveed Sattar, Paul Welsh, Ying Liu, Norbert Perrimon, Karteek Popuri, Mirza Faisal Beg, Nicholas McGranahan, Allan Hackshaw, Danna M Breen, Stephen O'Rahilly, Nicolai J Birkbak, Hugo J W L Aerts, Mariam Jamal-Hanjani, Charles Swanton
Cancer-associated cachexia (CAC) is a major contributor to morbidity and mortality in individuals with non-small cell lung cancer. Key features of CAC include alterations in body composition and body weight. Here, we explore the association between body composition and body weight with survival and delineate potential biological processes and mediators that contribute to the development of CAC. Computed tomography-based body composition analysis of 651 individuals in the TRACERx (TRAcking non-small cell lung Cancer Evolution through therapy (Rx)) study suggested that individuals in the bottom 20th percentile of the distribution of skeletal muscle or adipose tissue area at the time of lung cancer diagnosis, had significantly shorter lung cancer-specific survival and overall survival...
April 2023: Nature Medicine